어플

Three companies, including Hyundai Pharmaceuticals, were fined up to KRW 1.6 billion for accounting violations

Business / 김지선 / 09/14/2023 02:44 AM
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] At the 16th meeting on the 13th, the Financial Services Commission decided to impose fines on three companies, including Hyundai Pharmaceutical, company officials and accounting firms, who prepared and disclosed financial statements in violation of accounting standards.

Hyundai Pharmaceutical, which has the largest fine, was fined 1.6578 billion won for writing in violation of accounting standards. On the same charges, two people, including the former CEO, were fined 331.4 million won, while the Korea Accounting Corporation, which neglected the audit process, was fined 60.9 million won.

The Financial Services Commission imposed a fine of 553.6 million won on DA Technology for the same charges. Three former CEOs were charged 165.9 million won and 82.5 million won for accounting firms.

Four people, including the former CEO of listed company Mediforum, were also fined 331.4 million won for preparing financial statements in violation of accounting standards.

 

 

AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)

Related articles

[Exclusive] Samsung Electronics to Supply HBM3E 12-High Stacks to NVIDIA
DL E&C Executives Resign En Masse Following Fatal Construction Site Accident
POSCO Future M Terminates KRW 945 Billion ESS Cathode Material Supply Contract, Signs New LFP Partnership with CNGR
Hahn & Company Selects TKG Taekwang as Preferred Bidder for Sale of Semiconductor Parts Maker Solmix
Hyundai Motor Group Bolsters SDV and Autonomous Driving Capabilities with KRW 500.3 Billion Investment in 42dot
comments >

SNS